Sutro strengthens its immuno-oncology pipeline with two new ADCs

Sutro strengthens its immuno-oncology pipeline with two new ADCs

Submitted by admin on August 11, 2023 - 10:03am
Source: 
Clinical Trials Arena
News Tags: 
Sutro BioPharma
immuno-oncology
antibody-drug conjugate
Headline: 
Sutro strengthens its immuno-oncology pipeline with two new ADCs
snippet: 

Sutro Biopharma plans to submit investigational new drug (IND) applications for its two antibody-drug conjugates (ADCs), STRO-003 and STRO-004, in Q1 2024 and Q1 2025, respectively.

Do Not Allow Advertisers to Use My Personal information